CN1738592A - 作为uv吸收剂的三嗪衍生物 - Google Patents

作为uv吸收剂的三嗪衍生物 Download PDF

Info

Publication number
CN1738592A
CN1738592A CNA2004800024250A CN200480002425A CN1738592A CN 1738592 A CN1738592 A CN 1738592A CN A2004800024250 A CNA2004800024250 A CN A2004800024250A CN 200480002425 A CN200480002425 A CN 200480002425A CN 1738592 A CN1738592 A CN 1738592A
Authority
CN
China
Prior art keywords
acid
oil
alkyl
chemical compound
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800024250A
Other languages
English (en)
Chinese (zh)
Inventor
T·埃利斯
D·许林
E·博尔索斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Schweiz AG
Original Assignee
Ciba Spezialitaetenchemie Holding AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Spezialitaetenchemie Holding AG filed Critical Ciba Spezialitaetenchemie Holding AG
Publication of CN1738592A publication Critical patent/CN1738592A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/20—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with no nitrogen atoms directly attached to a ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/48—Two nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
CNA2004800024250A 2003-01-20 2004-01-13 作为uv吸收剂的三嗪衍生物 Pending CN1738592A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03405018.7 2003-01-20
EP03405018 2003-01-20

Publications (1)

Publication Number Publication Date
CN1738592A true CN1738592A (zh) 2006-02-22

Family

ID=32749023

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004800024250A Pending CN1738592A (zh) 2003-01-20 2004-01-13 作为uv吸收剂的三嗪衍生物

Country Status (13)

Country Link
US (1) US8187575B2 (enExample)
EP (1) EP1585493B1 (enExample)
JP (1) JP4671953B2 (enExample)
KR (1) KR101064902B1 (enExample)
CN (1) CN1738592A (enExample)
AT (1) ATE479665T1 (enExample)
AU (1) AU2004206724B2 (enExample)
BR (1) BRPI0406835A (enExample)
DE (1) DE602004028902D1 (enExample)
DK (1) DK1585493T3 (enExample)
ES (1) ES2349920T3 (enExample)
MX (1) MXPA05007671A (enExample)
WO (1) WO2004064797A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110522717A (zh) 2004-01-22 2019-12-03 迈阿密大学 局部辅酶q10制剂及其使用方法
FR2867188A1 (fr) * 2004-03-03 2005-09-09 Oreal Derives de s-triazine possedant un groupement para-alcoxyphenyle et au moins un groupement aminobenzalmaloniques greffes ; compositions cosmetiques contenant ces derives; utilisations desdits derives de s-tri
ES2264624B1 (es) * 2004-12-16 2007-11-01 Isdin, S.A. Nuevos derivados de triazina, asi como procedimientos para su obtencion y su utilizacion como agentes protectores contra la radiacion uv.
DE102005023634A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Wirkstoffkombinationen aus 2-(4'-(Diethylamino)-2'-hydoxybenzoyl)-benzoesäurehexylester und einem oder mehreren Glucosylglyceriden
US20070160549A1 (en) * 2005-12-21 2007-07-12 Hunt Sheri A UV-radiation protectant compositions
WO2008067928A1 (en) * 2006-12-04 2008-06-12 Isdin S.A. Uv absorbing compositions containing a pyrrolyltriazine
AU2008228764B2 (en) 2007-03-22 2014-05-08 Berg Llc Topical formulations having enhanced bioavailability
US7947311B2 (en) * 2007-08-10 2011-05-24 Lori Ann Porter Insect repellent concentrate formulation
US20090169655A1 (en) * 2007-08-10 2009-07-02 Lori Ann Porter Insect repellent formulation
EP2271325A4 (en) 2008-04-11 2011-11-09 Cytotech Labs Llc METHODS AND USE OF INDUCING APOPTOSIS IN CANCER CELLS
MX2011011619A (es) * 2009-05-01 2012-02-28 Signal Invest And Man Co Composicion antimicrobiana hidratante.
US20110020312A1 (en) 2009-05-11 2011-01-27 Niven Rajin Narain Methods for treatment of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
BR112012003915B1 (pt) * 2009-08-25 2017-07-25 L'oreal Cosmetic composition for keratin fibers
PL2544663T3 (pl) 2010-03-12 2018-09-28 Berg Llc Dożylne formulacje koenzymu Q10 (CoQ10) i sposoby ich zastosowania
JP5639569B2 (ja) * 2010-12-13 2014-12-10 株式会社 資生堂 水中油型乳化日焼け止め化粧料
US20120269867A1 (en) 2011-04-04 2012-10-25 Jimenez Joaquin J Methods of treating central nervous system tumors
KR102058256B1 (ko) 2011-06-17 2020-01-22 버그 엘엘씨 흡입성 약제학적 조성물들
KR101395814B1 (ko) * 2012-12-11 2014-05-16 한국화학연구원 플루오르알콕시기를 함유하는 트리아진계 반응성 자외선 안정제 및 그의 제조방법
EA032775B1 (ru) 2013-04-08 2019-07-31 Берг Ллк Способы лечения злокачественной опухоли с использованием комбинированной терапии с коферментом q10
US9901542B2 (en) 2013-09-04 2018-02-27 Berg Llc Methods of treatment of cancer by continuous infusion of coenzyme Q10
WO2017087576A1 (en) 2015-11-16 2017-05-26 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10
JP6867168B2 (ja) * 2017-01-04 2021-04-28 株式会社コーセー エアゾール型化粧料
EP3576847B1 (en) * 2017-02-03 2024-07-03 Edgewell Personal Care Brands, LLC Sunscreen compositions with natural waxes for improved water resistance
JP7373264B2 (ja) * 2017-11-28 2023-11-02 ポーラ化成工業株式会社 日焼け止め化粧料
WO2023063190A1 (ja) * 2021-10-13 2023-04-20 株式会社 資生堂 紫外線吸収粉末、紫外線吸収粉末を含む化粧料、分散体及び混合粉末、並びに紫外線吸収粉末の製造方法
WO2025134936A1 (ja) * 2023-12-21 2025-06-26 株式会社 資生堂 油中水型乳化組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH473604A (de) * 1965-02-19 1969-06-15 Ciba Geigy Verwendung von neuen Aryl-1,3,5-triazinen als Stabilisierungsmittel für nicht-textile organische Materialien
CH473605A (de) * 1965-04-20 1969-06-15 Ciba Geigy Verwendung von neuen Aryl-1,3,5-triazin-Derivaten als Stabilisierungsmittel für nicht-textile organische Materialien
CH686305A5 (de) * 1993-09-28 1996-02-29 Ciba Geigy Ag Verfahren zur Herstellung von 1,3,5-Triazinen.
GB9515048D0 (en) * 1995-07-22 1995-09-20 Ciba Geigy Ag Sunscreen compositions
DE19543730A1 (de) * 1995-11-23 1997-05-28 Ciba Geigy Ag Bis-Resorcinyl-Triazine
EP0818450B1 (de) * 1996-07-08 2003-01-15 Ciba SC Holding AG Triazinderivate als UV-Filter in Sonnenschutzmitteln
EP0941217B1 (en) * 1996-11-20 2003-09-17 Ciba SC Holding AG Symmetrical triazine derivatives
SG75939A1 (en) * 1998-04-09 2000-10-24 Ciba Sc Holding Ag Diresorcinyl-alkoxy-and-aryloxy-s-triazines
ES2302916T3 (es) * 2002-03-12 2008-08-01 Ciba Holding Inc. Composiciones absorbentes de rayos uv que comprenden un compuesto hidroxifeniltriazina.
MX267068B (es) * 2003-03-24 2009-05-29 Ciba Sc Holding Ag Derivados simetricos de triazina.
US7166275B2 (en) * 2003-07-11 2007-01-23 Isp Investments Inc. Compositions containing phenethyl aryl esters as solubilizing agents for active organic compounds
US7132097B2 (en) * 2004-10-08 2006-11-07 Isp Investments Inc. Sunscreen compositions
US7208143B2 (en) * 2004-09-29 2007-04-24 Isp Investments Inc. Antiperspirant compositions

Also Published As

Publication number Publication date
JP4671953B2 (ja) 2011-04-20
DK1585493T3 (da) 2010-12-06
US20060153783A1 (en) 2006-07-13
EP1585493A1 (en) 2005-10-19
MXPA05007671A (es) 2005-09-30
EP1585493B1 (en) 2010-09-01
BRPI0406835A (pt) 2005-12-27
KR20050094447A (ko) 2005-09-27
ATE479665T1 (de) 2010-09-15
KR101064902B1 (ko) 2011-09-16
ES2349920T3 (es) 2011-01-13
DE602004028902D1 (de) 2010-10-14
AU2004206724B2 (en) 2010-06-24
AU2004206724A1 (en) 2004-08-05
WO2004064797A1 (en) 2004-08-05
US8187575B2 (en) 2012-05-29
JP2006515613A (ja) 2006-06-01

Similar Documents

Publication Publication Date Title
CN1738592A (zh) 作为uv吸收剂的三嗪衍生物
CN1642522A (zh) 含有羟基苯基三嗪化合物的紫外吸收剂组合物
CN1246303C (zh) 新的茚满亚基化合物
CN1625386A (zh) 微粉颜料混合物
US7407648B2 (en) Merocyanine derivatives for cosmetic use
US20110305650A1 (en) Stabilization of cosmetic compositions
CN1554325A (zh) 氨基取代的羟基二苯酮作为化妆品和药物制剂中的光稳定紫外滤除剂的应用
US20090068129A1 (en) Aminophenylbenzothiazole compounds
CN1671759A (zh) 共聚物及其在个人护理组合物中的应用
CN101166511B (zh) 苯并三唑衍生物用于光稳定的用途
GB2458362A (en) Dimeric benzylidene malonates and derivatives thereof for use as UV-light absorbers in cosmetics
CN1382433A (zh) 含丙二酸二烷基酯的防晒剂组合在化妆品和药物制剂中的用途
CN1852696A (zh) 含有二乙氨基羟基苯甲酰基苯甲酸己酯的粉状制剂
US10449135B2 (en) Solublizing agents for UV filters in cosmetic formulations
CN1852699A (zh) 包含2,4,6－三苯胺基对－(碳－2′－乙基己基－1′－氧基)－1,3,5－三嗪和二乙氨基羟基苯甲酰基苯甲酸己基酯的混合物的粉末制剂
CN1774426A (zh) 均三嗪衍生物
CN1852697A (zh) 卤代羟基二苯基醚化合物在皮肤处理中的应用
CN1852698A (zh) 含有2,4,6－三苯胺基－对(羰基－2′－乙基己基－1′－氧基)－1,3,5－三嗪的粉状制剂
CN1553888A (zh) 亚联苯基化合物
US20080019929A1 (en) Micro-Particulate Organic Uv Absorber Composition
CN1386493A (zh) 包含烯氨基三嗪作为防日光老化剂的化妆品或药物制剂以及新型烯氨基三嗪
HK1062432B (en) Novel indanylidene compounds
CN1950058A (zh) 作为新的UV吸收剂的亚苄基－β－二羰基化合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication